Successful immune tolerance treatment with monoclonal or recombinant factor VIII concentrates in high responding inhibitor patients

Vox Sanguinis

Volumn 77, Issue SUPPL. 1, 1999, Pages 65-69

  Rocino, Angiola ^a   De Biasi, Raffaello ^a  

^a Divisione de Ematologiaosi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADOLESCENT; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; HUMAN; IMMUNOLOGICAL TOLERANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0032881728     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056720     Document Type: Conference Paper

References (7)

1. Brackmann HH: Induced tolerance in factor VIII inhibitor patients. Prog Clin Biol Res 1984;150:181-195.
2. Ewing NP, Sanders NL, Dietrich SL, Kasper CK: Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors. JAMA 1988;259:65-68.
3. Van Leeuwen EF, Mauser-Bunscholen EP, van Dijken PJ, Kok AJ, Sjamsvedin-Visset EJH, Sixma JJ: Disappearance of factor VIII:C antibodies in patients with haemophilia upon frequent administration of factor VIII in intermediate or low dose. Br J Haematol 1986;64:291-297.
4. Mauser-Bunschoten EP, Nieuwenhuis HK, Rosendaal G, van den Berg HM. Low dose immune tolerance induction in hemophilia A patients with inhibitors. Blood 1995;86:983-988.
5. Gruppo RA, Valdez LP, Stout RD. Inductions of immune tolerance in patients with hemophilia A and inhibitors. Am J Pediatr Hematol Oncol 1992;14:82-87.
6. Kreuz W, Mentzer D, Auerswald G, Becker S, Joseph-Steiner J: Successful immune tolerance therapy of FVIII-Inhibitor in children after changing from high to intermediate purity FVIII concentrate. Haemophilia 1996;2(suppl 1:)abstr 19.
7. Di Michele DM, Kroner BL and the ISTH Factor VIII/IX Subcommittee: Analysis of the North American Immune Tolerance Registry (NAITR) (1993-1997): Current practice implications. Blood 1997;90(suppl 1):abstr 156.